Rationale for and conduct of a phase I clinical trial with interferon alfa-2b plus doxorubicin.
Von Hoff, D D
Rationale for and conduct of a phase I clinical trial with interferon alfa-2b plus doxorubicin. [electronic resource] - Seminars in oncology Sep 1986 - 72-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
0093-7754
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Doxorubicin--administration & dosage
Drug Evaluation
Humans
Interferon Type I--administration & dosage
Neoplasms--therapy
Recombinant Proteins--administration & dosage
Tumor Stem Cell Assay
Rationale for and conduct of a phase I clinical trial with interferon alfa-2b plus doxorubicin. [electronic resource] - Seminars in oncology Sep 1986 - 72-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
0093-7754
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Doxorubicin--administration & dosage
Drug Evaluation
Humans
Interferon Type I--administration & dosage
Neoplasms--therapy
Recombinant Proteins--administration & dosage
Tumor Stem Cell Assay